why choose us

CME Courses

Showing 70 of 4,235 result(s)
Course: The Latest Updates on the Role of HER2-Low and HER2-Ultralow in Treatment Selection for Metastatic Breast Cancer

Description: The landscape regarding diagnosis and treatment of human epidermal growth factor receptor 2 (HER2)-low and -ultralow mBC is evolvi...

CME Credit: 1.00

Course: ER+/HER2-Low Metastatic with ESR1 and PIK3CA Mutations

Description: Stay current with the rapidly evolving breast cancer treatment landscape through this dynamic on demand educational series, develo...

CME Credit: 0.25